CMS says it will review breakthrough medical devices before FDA approval to help determine whether Medicare will cover them. On today’s 4sight Health Roundup, David W. Johnson and Julie Murchinson discuss the pros and cons of this plan and how it will affect medical innovation and investors. Listen on the new episode of the 4sight Health Roundup podcast moderated by David Burda.
David Johnson is CEO of 4sight Health.
Julie Vaughan Murchinson is Partner of Transformation Capital and former CEO of Health Evolution.
David Burda is News Editor and Columnist of 4sight Health.
To bring your own revolutionary ideas to life, sponsor this podcast. Email info@4sighthealth.com for more.
Listen on your podcast app or on the 4sight Health YouTube Channel.
Subscribe on Apple Podcasts, Spotify, Google Podcasts and YouTube.
4sight Health Roundup (for Healthcare Executives)